Studies of the dual SGLT1/2 inhibitor canagliflozin and the SGLT1 inhibitor SGL5213 showed that these agents reversed the expansion of Firmicutes and contraction of Bacteroidetes in the gut microbiota of mice with adenine-induced renal failure [189, 190]. Here, SLC5A1 is linked to Renal insufficiency.